These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26864945)

  • 1. Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells.
    Ren Z; Gu X; Lu B; Chen Y; Chen G; Feng J; Lin J; Zhang Y; Peng H
    J Cell Mol Med; 2016 Jun; 20(6):1095-105. PubMed ID: 26864945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
    Gu X; Huang Z; Ren Z; Tang X; Xue R; Luo X; Peng S; Peng H; Lu B; Tian J; Zhang Y
    J Med Chem; 2017 Feb; 60(3):928-940. PubMed ID: 28068095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells.
    Tang X; Gu X; Ai H; Wang G; Peng H; Lai Y; Zhang Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):801-5. PubMed ID: 22209486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells.
    Kopecka J; Porto S; Lusa S; Gazzano E; Salzano G; Giordano A; Desiderio V; Ghigo D; Caraglia M; De Rosa G; Riganti C
    Oncotarget; 2015 Oct; 6(31):31461-78. PubMed ID: 26372812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor agents. 293. Nontoxic dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate (DDB) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs.
    Hung HY; Ohkoshi E; Goto M; Bastow KF; Nakagawa-Goto K; Lee KH
    J Med Chem; 2012 Jun; 55(11):5413-24. PubMed ID: 22612652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.
    Jin J; Sun H; Wei H; Liu G
    Invest New Drugs; 2007 Apr; 25(2):95-105. PubMed ID: 16937080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
    Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
    Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
    Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
    Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
    Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
    Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
    Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
    Oh JH; Lee TJ; Park JW; Kwon TK
    Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
    Gu X; Jiang Y; Qu Y; Chen J; Feng D; Li C; Yin X
    Eur J Med Chem; 2018 Feb; 145():379-388. PubMed ID: 29335204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
    Zou ZH; Lan XB; Qian H; Huang WL; Li YM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthetic ajoene analog SPA3015 induces apoptotic cell death through crosstalk between NF-κB and PPARγ in multidrug-resistant cancer cells.
    Hwang JW; Cho H; Lee JY; Jeon Y; Kim SN; Lee SJ; Bae GU; Yoon S; Jeon R; Kim YK
    Food Chem Toxicol; 2016 Oct; 96():35-42. PubMed ID: 27449564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors.
    Gu X; Ren Z; Tang X; Peng H; Zhao Q; Lai Y; Peng S; Zhang Y
    Eur J Med Chem; 2012 May; 51():137-44. PubMed ID: 22405646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K; Biswas MK; Choudhuri SK
    J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.